Diligence memo · auto-generated · as of July 2, 2026
Aseptica, Inc.
Aseptica, Inc. looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Aseptica, Inc. operates in Biotechnology, based in PORT ORCHARD.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Aseptica, Inc. has raised $750K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $750K on —.
Valuation (modeled)modeled
Provath models Aseptica, Inc. at approximately $1.0M (range $400K–$1.8M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.09× the median modeled value of Pre-Seed Biotechnology companies (927 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
No dated round to assess.
Comparablesmixed
Capital scale ranks ahead of 15% of Biotechnology peers (4293 compared).
Modeled value ranks above 3% of those peers.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.